These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6951091

  • 1. Combined treatments with vitamin A and 5-fluorouracil and the growth of allotransplantable and syngeneic tumors in mice.
    Tomita Y, Himeno K, Nomoto K, Endo H, Hirohata T.
    J Natl Cancer Inst; 1982 May; 68(5):823-7. PubMed ID: 6951091
    [Abstract] [Full Text] [Related]

  • 2. [Potentiation of chemotherapeutic activity by a Chinese herb medicine juzen-taiho-toh].
    Komiyama K, Hirokawa Y, Zhibo Y, Umezawa I, Hata T.
    Gan To Kagaku Ryoho; 1988 May; 15(5):1715-9. PubMed ID: 3130806
    [Abstract] [Full Text] [Related]

  • 3. Augmentation of tumor immunity against syngeneic tumors in mice by beta-carotene.
    Tomita Y, Himeno K, Nomoto K, Endo H, Hirohata T.
    J Natl Cancer Inst; 1987 Apr; 78(4):679-81. PubMed ID: 3470543
    [Abstract] [Full Text] [Related]

  • 4. Immunological role of vitamin A and its related substances in prevention of cancer.
    Tomita Y.
    Nutr Cancer; 1983 Apr; 5(3-4):187-94. PubMed ID: 6669479
    [Abstract] [Full Text] [Related]

  • 5. [Potentiation of the therapeutic effect of chemotherapy and hyperthermia on experimental tumor and reduction of immunotoxicity of mitomycin C by juzen-taiho-toh, a Chinese herbal medicine].
    Komiyama K, Zhibo Y, Umezawa I.
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):251-7. PubMed ID: 2493224
    [Abstract] [Full Text] [Related]

  • 6. Potentiation by vitamin A of the action of anticancer agents against murine tumors.
    Nakagawa M, Yamaguchi T, Ueda H, Shiraishi N, Komiyama S, Akiyama S, Ogata J, Kuwano M.
    Jpn J Cancer Res; 1985 Sep; 76(9):887-94. PubMed ID: 3932288
    [Abstract] [Full Text] [Related]

  • 7. Antitumor activity of an extract of Cordyceps sinensis (Berk.) Sacc. against murine tumor cell lines.
    Yoshida J, Takamura S, Yamaguchi N, Ren LJ, Chen H, Koshimura S, Suzuki S.
    Jpn J Exp Med; 1989 Aug; 59(4):157-61. PubMed ID: 2601113
    [Abstract] [Full Text] [Related]

  • 8. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON, Rais R, Shi J, Schinazi RF, Naguib FN, el Kouni MH.
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [Abstract] [Full Text] [Related]

  • 9. Relationship between antitumor effect and metabolites of 5-fluorouracil in combination treatment with 5-fluorouracil and guanosine in ascites sarcoma 180 tumor system.
    Iigo M, Kuretani K, Hoshi A.
    Cancer Res; 1983 Dec; 43(12 Pt 1):5687-94. PubMed ID: 6640523
    [Abstract] [Full Text] [Related]

  • 10. Allogeneic versus syngeneic killer splenocytes as effector cells for the induction of graft-versus-tumor effect.
    Morecki S, Yacovlev E, Gelfand Y, Vilensky A, Slavin S.
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):40-8. PubMed ID: 14752778
    [Abstract] [Full Text] [Related]

  • 11. Antitumor activity of Corynebacterium parvum and retinyl palmitate used in combination on the Lewis lung carcinoma.
    Pavelic ZP, Dave S, Bialkowski S, Priore RL, Greco WR.
    Cancer Res; 1980 Dec; 40(12):4617-21. PubMed ID: 7438095
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K, Morimoto M, Nomoto K.
    Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
    [Abstract] [Full Text] [Related]

  • 13. Fifty-five percent complete remission of mammary carcinoma in mice with 5-fluorouracil and chloroquine.
    Shoemaker JP.
    Cancer Res; 1978 Sep; 38(9):2700-2. PubMed ID: 679173
    [Abstract] [Full Text] [Related]

  • 14. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
    Klubes P, Cerna I.
    Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
    [Abstract] [Full Text] [Related]

  • 15. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ, Tanimoto T, Kohno K, Ikeda M, Kurimoto M.
    Cancer Res; 1997 Oct 15; 57(20):4557-63. PubMed ID: 9377569
    [Abstract] [Full Text] [Related]

  • 16. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice.
    Niederkorn J, Streilein JW, Shadduck JA.
    Invest Ophthalmol Vis Sci; 1981 Mar 15; 20(3):355-63. PubMed ID: 6782034
    [Abstract] [Full Text] [Related]

  • 17. The antitumor effect of hyperthermia combined with fluorouracil and its analogues.
    Harada S, Ping L, Obara T, Oikawa H, Miyata M, Matsuo M, Takahashi T, Yanagisawa T.
    Radiat Res; 1995 May 15; 142(2):232-41. PubMed ID: 7724740
    [Abstract] [Full Text] [Related]

  • 18. Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice.
    Zeis M, Frenzke H, Schmitz N, Uharek L, Steinmann J.
    Bone Marrow Transplant; 2002 Feb 15; 29(3):213-21. PubMed ID: 11859393
    [Abstract] [Full Text] [Related]

  • 19. Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen.
    Clark DA, Gorczynski RM, Blajchman MA.
    Transfusion; 2008 May 15; 48(5):814-21. PubMed ID: 18298594
    [Abstract] [Full Text] [Related]

  • 20. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
    Vallera DA, Mentzer SJ, Maizel SE.
    Cancer Res; 1982 Feb 15; 42(2):397-404. PubMed ID: 7055792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.